Scouted/The Daily Beast/Badesofa.Scouted selects products independently. If you purchase something from our posts, we may earn a small commission.Real self-care enthusiasts know there’s an art to taking a bath—we’re not children, after all. Setting the mood with ambient lighting, tossing in your ... Read more
The Daily Beast - Dec 28
Homewood, IL, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting supplements. If you purchase through links in this article, a commission may be earned at no ad... Read more
Benzinga - Dec 28
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Herbal Transdermal Wellness Patch Category Examined as Consumers Compare Prescription GLP-1 Costs With Non-Prescription Alternatives Ahead of New Year Weight Loss SeasonDisclaimer: This article is for informational purposes only. It is not medical advic... Read more
Benzinga - Dec 26
'I am so glad I went for it, my sleep has improved a lot,' one shopper said after the mattress was cut in their Boxing Day sale Read more
Express - Dec 26
The holidays can be full of joy, good food, and quality time with loved ones. But with all the joy and chaos often comes disrupted sleep, which makes it difficult to transition back into a 9-to-5 schedule once the new year arrives. The sleep company iSense has always been driven by a single missi... Read more
Hollywood Life - Dec 23
The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight reduction as a needle-free alternative. Read more
Fox News - Dec 23
On Monday, the US Food and Drug Administration approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy. CNN's Jacqueline Howard explains when it will be available and how much it could cost. Discover more videos, including live streams and exclusive storytelling, on our Watch page. Read more
Cnn - Dec 23
This launch—and the recent cagrisema filing—should help Novo regain its footing against Lilly. Read more
Morningstar - Dec 23
The approval of Novo Nordisk's (NYSE:NVO)oral Wegovy is bringing new interest to health care and pharmaceutical ETFs that provide access to the growing GLP-1 market without requiring investors to choose one specific company.• What should traders watch with XLV?Broad funds like the Health Care Sel... Read more
Benzinga - Dec 23
The FDA has approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, which retains the same active ingredient as the original, allowing for an alternative to the weekly injections currently offered. CNN's Meg Tirrell reports. Read more
Cnn - Dec 23
